IGM Biosciences Inc (IGMS)
8.85
-0.92
(-9.37%)
USD |
NASDAQ |
Nov 21, 16:00
8.75
-0.10
(-1.13%)
After-Hours: 20:00
IGM Biosciences Profit Margin (Quarterly): -11.91K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.91K% |
| June 30, 2024 | -3.82K% |
| March 31, 2024 | -10.02K% |
| December 31, 2023 | -9.32K% |
| September 30, 2023 | -12.18K% |
| Date | Value |
|---|---|
| June 30, 2023 | -14.38K% |
| March 31, 2023 | -11.36K% |
| December 31, 2022 | -14.13K% |
| September 30, 2022 | -17.53K% |
| June 30, 2022 | -16.01K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-17.53K%
Minimum
Sep 2022
-3.82K%
Maximum
Jun 2024
-12.07K%
Average
-12.04K%
Median
Profit Margin (Quarterly) Benchmarks
| Moderna Inc | 0.70% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -134.1% |
| Return on Assets | -57.40% |
| Return on Invested Capital | -134.1% |
| Operating Margin (Quarterly) | -12.48K% |
| Return on Net Operating Assets | -303.2% |